推荐应用
Fas, also known as APO‑1 or CD95, belongs to the death receptor subfamily of the TNF receptor superfamily and is designated TNFRSF6. All appear to block the extrinsic apoptosis pathway induced by the Fas ligand (FasL, TNFSF6), a type II transmembrane protein of the TNF family that can be expressed on activated T‑lymphocytes, NK cells and cells in immune privileged sites, or shed in soluble form. Engagement of FAS induces oligomerization of preformed Fas trimers. The activated receptor recruits the adaptor molecule FADD to form the Death‑Inducing Signaling Complex (DISC). Upon activation, caspases in the DISC initiate the apoptotic signaling cascade. Fas is prominent in epithelial cells, hepatocytes, activated mature lymphocytes, virus-transformed lymphocytes and tumor cells. It is an essential mediator in the activation‑induced death of T lymphocytes that terminates the immune reaction. In immune‑privileged tissues, infiltrating Fas‑bearing lymphocytes and inflammatory cells are killed by FasL engagement. Both humans and mice with genetic defects in Fas accumulate abnormal lymphocytes and develop systemic autoimmunity. The Fas pathway also appears to cross‑communicate with the BIM (mitochondrial/intrinsic) apoptosis pathway.
高纯度、高活性、低内毒素、高批间一致性
产品数据

-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】HER2与HER3:ErbB受体家族协同靶向治疗的核心工具蛋白
164
2026-08-31
【应用方向】HER2:抗体药物研发的核心工具蛋白
172
2026-08-31
【应用方向】抗体药研发中常见靶点蛋白及其应用
222
2026-08-31
【应用方向】靶点蛋白在抗体药研发中的应用
165
2026-08-31
【应用方向】GPC3:HCC靶向治疗的核心靶点与药物研发探索
1993
2026-04-24
【应用方向】TROP2:从分子机制到实体瘤靶向治疗的研究进展
1942
2026-04-24
【应用方向】4-1BB-4-1BBL共刺激轴的T细胞活化机制
1179
2026-04-22
【应用方向】TNFR蛋白家族概述
1126
2026-04-21
【应用方向】Klotho蛋白:编织生命之线的抗衰老分子
1316
2026-04-20
【应用方向】药靶明星 | FGFRs家族蛋白解析
970
2026-04-20
【应用方向】解析Fc受体:抗体药物研发的核心靶点与评价基石
985
2026-04-20
【应用方向】FcγR家族:抗体药物研发的基石与核心靶点
1076
2026-04-20
【应用方向】CD47-SIRPα轴研究工具与药物开发应用
886
2026-04-20
【应用方向】HER2靶点蛋白:驱动肿瘤靶向治疗的核心力量
14657
2026-03-02
【技术讲解】细胞因子科学选型--常见问题解答
11266
2026-09-21





